|
1
|
Han SJ, Jung SY, Wu SP, Hawkins SM, Park
MJ, Kyo S, Qin J, Lydon JP, Tsai SY, Tsai MJ, et al: Estrogen
receptor β modulates apoptosis complexes and the inflammasome to
drive the pathogenesis of endometriosis. Cell. 163:960–974. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ahn SH, Edwards AK, Singh SS, Young SL,
Lessey BA and Tayade C: IL-17A contributes to the pathogenesis of
endometriosis by triggering proinflammatory cytokines and
angiogenic growth factors. J Immunol. 195:2591–2600. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kocbek V, Grandi G, Blank F, Wotzkow C,
Bersinger NA, Mueller MD, Kyo S and McKinnon BD: TNFα-induced IKKβ
complex activation influences epithelial, but not stromal cell
survival in endometriosis. Mol Hum Reprod. 22:768–777. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chan RW, Ng EH and Yeung WS:
Identification of cells with colony-forming activity, self-renewal
capacity, and multipotency in ovarian endometriosis. Am J Pathol.
178:2832–2844. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vouk K, Hevir N, Ribić-Pucelj M,
Haarpaintner G, Scherb H, Osredkar J, Möller G, Prehn C, Rižner TL
and Adamski J: Discovery of phosphatidylcholines and sphingomyelins
as biomarkers for ovarian endometriosis. Hum Reprod. 27:2955–2965.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barbieri M, Somigliana E, Oneda S, Ossola
MW, Acaia B and Fedele L: Decidualized ovarian endometriosis in
pregnancy: A challenging diagnostic entity. Hum Reprod.
24:1818–1824. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim TH, Yoo JY, Wang Z, Lydon JP, Khatri
S, Hawkins SM, Leach RE, Fazleabas AT, Young SL, Lessey BA, et al:
ARID1A is essential for endometrial function during early
pregnancy. PLoS Genet. 11:e10055372015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Borrelli GM, Abrão MS, Taube ET,
Darb-Esfahani S, Köhler C, Chiantera V and Mechsner S: (Partial)
Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating
endometriosis, endometriomas and involved pelvic sentinel lymph
nodes. Mol Hum Reprod. 22:329–337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Raible MD: Pathophysiology and treatment
of endometriosis. Am J Hosp Pharm. 38:1696–1701. 1981.PubMed/NCBI
|
|
10
|
Gazvani R and Templeton A: Peritoneal
environment, cytokines and angiogenesis in the pathophysiology of
endometriosis. Reproduction. 123:217–226. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang YJ, Jeung IC, Park A, Park YJ, Jung
H, Kim TD, Lee HG, Choi I and Yoon SR: An increased level of IL-6
suppresses NK cell activity in peritoneal fluid of patients with
endometriosis via regulation of SHP-2 expression. Hum Reprod.
29:2176–2189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suen JL, Chang Y, Chiu PR, Hsieh TH, His
E, Chen YC, Chen YF and Tsai EM: Serum level of IL-10 is increased
in patients with endometriosis, and IL-10 promotes the growth of
lesions in a murine model. Am J Pathol. 184:464–471. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang JF, Deng Y, Xue W, Zheng TP and Sun
AJ: Increased expression of Interleukin 37 in the eutopic and
ectopic endometrium of patients with ovarian endometriosis. Reprod
Sci. 23:244–248. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Taylor RN, Kane MA and Sidell N:
Pathogenesis of endometriosis: Roles of retinoids and inflammatory
pathways. Semin Reprod Med. 33:246–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taylor RN, Yu J, Torres PB, Schickedanz
AC, Park JK, Mueller MD and Sidell N: Mechanistic and therapeutic
implications of angiogenesis in endometriosis. Reprod Sci.
16:140–146. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Attia GR, Zeitoun K, Edwards D, Johns A,
Carr BR and Bulun SE: Progesterone receptor isoform A but not B is
expressed in endometriosis. J Clin Endocrinol Metab. 85:2897–2902.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Osteen KG, Bruner-Tran KL and Eisenberg E:
Reduced progesterone action during endometrial maturation: A
potential risk factor for the development of endometriosis. Fertil
Steril. 83:529–537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luk J, Seval Y, Kayisli UA, Ulukus M,
Ulukus CE and Arici A: Regulation of interleukin-8 expression in
human endometrial endothelial cells: A potential mechanism for the
pathogenesis of endometriosis. J Clin Endocrinol Metab.
90:1805–1811. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nothnick W and Alali Z: Recent advances in
the understanding of endometriosis: The role of inflammatory
mediators in disease pathogenesis and treatment. F1000Res. 5:pii:
F1000 Faculty Rev-186. 2016.PubMed/NCBI
|
|
20
|
Platteeuw L and D'Hooghe T: Novel agents
for the medical treatment of endometriosis. Curr Opin Obstet
Gynecol. 26:243–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bruner-Tran KL, Herington JL, Duleba AJ,
Taylor HS and Osteen KG: Medical management of endometriosis:
Emerging evidence linking inflammation to disease pathophysiology.
Minerva Ginecol. 65:199–213. 2013.PubMed/NCBI
|
|
22
|
Yang YK, Yang C, Chan W, Wang Z, Deibel KE
and Pomerantz JL: Molecular determinants of scaffold-induced linear
ubiquitinylation of B cell lymphoma/leukemia 10 (Bcl10) during T
cell receptor and oncogenic caspase recruitment domain-containing
protein 11 (CARD11) signaling. J Biol Chem. 291:25921–25936. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thome M and Tschopp J: TCR-induced
NF-kappaB activation: A crucial role for Carma1, Bcl10 and MALT1.
Trends Immunol. 24:419–424. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Davis RE, Ngo VN, Lenz G, Tolar P, Young
RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, et al:
Chronic active B-cell-receptor signalling in diffuse large B-cell
lymphoma. Nature. 463:88–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
da Silva Almeida AC, Abate F, Khiabanian
H, Martinez-Escala E, Guitart J, Tensen CP, Vermeer MH, Rabadan R,
Ferrando A and Palomero T: The mutational landscape of cutaneous T
cell lymphoma and Sézary syndrome. Nat Genet. 47:1465–1470. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giannakis M, Hodis E, Mu Jasmine X,
Yamauchi M, Rosenbluh J, Cibulskis K, Saksena G, Lawrence MS, Qian
ZR, Nishihara R, et al: RNF43 is frequently mutated in colorectal
and endometrial cancers. Nat Genet. 46:1264–1266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mouradov D, Sloggett C, Jorissen RN, Love
CG, Li S, Burgess AW, Arango D, Strausberg RL, Buchanan D, Wormald
S, et al: Colorectal cancer cell lines are representative models of
the main molecular subtypes of primary cancer. Cancer Res.
74:3238–3247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shain AH, Garrido M, Botton T, Talevich E,
Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, et al:
Exome sequencing of desmoplastic melanoma identifies recurrent
NFKBIE promoter mutations and diverse activating mutations in the
MAPK pathway. Nat Genet. 47:1194–1199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li X, Zhang Y, Zhao L, Wang L, Wu Z, Mei
Q, Nie J, Li X, Li Y, Fu X, et al: Whole-exome sequencing of
endometriosis identifies frequent alterations in genes involved in
cell adhesion and chromatin-remodeling complexes. Hum Mol Genet.
23:6008–6021. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee AW, Templeman C, Stram DA, Beesley J,
Tyrer J, Berchuck A, Pharoah PP, Chenevix-Trench G and Pearce CL:
Ovarian Cancer Association Consortium: Evidence of a genetic link
between endometriosis and ovarian cancer. Fertil Steril. 105:35–43.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matsumoto T, Yamazaki M, Takahashi H,
Kajita S, Suzuki E, Tsuruta T and Saegusa M: Distinct β-catenin and
PIK3CA mutation profiles in endometriosis-associated ovarian
endometrioid and clear cell carcinomas. Am J Clin Pathol.
144:452–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Worley MJ Jr, Liu S, Hua Y, Kwok JS,
Samuel A, Hou L, Shoni M, Lu S, Sandberg EM, Keryan A, et al:
Molecular changes in endometriosis-associated ovarian clear cell
carcinoma. Eur J Cancer. 51:1831–1842. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Anglesio MS, Papadopoulos N, Ayhan A,
Nazeran TM, Noë M, Horlings HM, Lum A, Jones S, Senz J, Seckin T,
et al: Cancer-associated mutations in endometriosis without cancer.
N Engl J Med. 376:1835–1848. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yan H, Parsons DW, Jin G, McLendon R,
Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ,
et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med.
360:765–773. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zou Y, Zeng Y, Zhang DF, Zou SH, Cheng YF
and Yao YG: IDH1 and IDH2 mutations are frequent in Chinese
patients with acute myeloid leukemia but rare in other types of
hematological disorders. Biochem Biophys Res Commun. 402:378–383.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kumar S, Stecher G and Tamura K: MEGA7:
Molecular evolutionary genetics analysis version 7.0 for bigger
datasets. Mol Biol Evol. 33:1870–1874. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schwarz JM, Cooper DN, Schuelke M and
Seelow D: MutationTaster2: Mutation prediction for the
deep-sequencing age. Nat Methods. 11:361–362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kumar P, Henikoff S and Ng PC: Predicting
the effects of coding non-synonymous variants on protein function
using the SIFT algorithm. Nat Protoc. 4:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Blonska M and Lin X: NF-κB signaling
pathways regulated by CARMA family of scaffold proteins. Cell Res.
21:55–70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lenz G, Davis RE, Ngo VN, Lam L, George
TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, et al: Oncogenic
CARD11 mutations in human diffuse large B cell lymphoma. Science.
319:1676–1679. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kan Z, Zheng H, Liu X, Li S, Barber TD,
Gong Z, Gao H, Hao K, Willard MD, Xu J, et al: Whole-genome
sequencing identifies recurrent mutations in hepatocellular
carcinoma. Genome Res. 23:1422–1433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Arai E, Sakamoto H, Ichikawa H, Totsuka H,
Chiku S, Gotoh M, Mori T, Nakatani T, Ohnami S, Nakagawa T, et al:
Multilayer-omics analysis of renal cell carcinoma, including the
whole exome, methylome and transcriptome. Int J Cancer.
135:1330–1342. 2014. View Article : Google Scholar : PubMed/NCBI
|
